| All cancer patients (n. 28) | TIVA-TCI (n. 14) | BAL (n. 14) | P TIVA-TCI vs. BAL |
---|---|---|---|---|
Age (yrs) | 62.04 ± 8.63 | 63.2 ± 6.8 | 61.2 ± 10.8 | 0.57 |
Sex , n (%) | Â | Â | Â | Â |
 males | 23 (82.1%) | 12 (85.7%) | 11 (78.6%) | 0.62 |
 females | 5 (17.9%) | 2 (14.3%) | 3 (21.4%) |  |
Histological type of cancer | Â | Â | Â | Â |
 High grade urothelial carcinoma | 28 (100%) | 14 (100%) | 14 (100%) | 1.00 |
pT, n (%) | Â | Â | Â | Â |
 1-2 | 11 (39.3%) | 6 (42.9%) | 5 (35.7%) | 0.70 |
 3 | 17 (60.7%) | 8 (57.1%) | 9 (64.3%) |  |
pN, n (%) | Â | Â | Â | Â |
 0 | 22 (78.6%) | 12 (85.7%) | 10 (71.4%) | 0.34 |
 1 | 2 (7.1%) | 0 | 2 (14.3%) |  |
 2 | 4 (14.3%) | 2 (14.3%) | 2 (14.3%) |  |
ASA, n (%): | Â | Â | Â | Â |
 I-II | 18 (64.3%) | 9 (64.3%) | 9 (64.3%) | 1.00 |
 III | 10 (35.7%) | 5 (35.7%) | 5 (35.7%) |  |
Weight (BMI ) | 25.8 ± 4.2 | 27.1 ± 5.9 | 25.1 ± 3.0 | 0.55 |
Time of surgery (h) | 3.12 ± 0.59 | 3.08 ± 0.58 | 3.17 ± 0.56 | 0.27 |
Time of anaesthesia (h) | 3.27 ± 0.48 | 3.18 ± 0.45 | 3.35 ± 0.51 | 0.42 |
Time of hospitalization (days) | 13.29 ± 1.00 | 13.58 ± 0.99 | 13.00 ± 0.95 | 0.16 |
Metastasis after surgery, n (%) | 4 (14.3%) | 1 (7.1%) | 3 (21.4%) | 0.28 |
Death from cancer, n (%) | 5 (17.9%) | 1 (7.1%) | 4 (28.6%) | 0.14 |
Death from any cause, n (%) | 7 (25.0%) | 2 (14.3%) | 5 (35.7%) | 0.19 |